| __timestamp | Amphastar Pharmaceuticals, Inc. | MiMedx Group, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 159205000 | 12665000 |
| Thursday, January 1, 2015 | 174172000 | 20202000 |
| Friday, January 1, 2016 | 150976000 | 32407000 |
| Sunday, January 1, 2017 | 149380000 | 35219000 |
| Monday, January 1, 2018 | 187681000 | 36386000 |
| Tuesday, January 1, 2019 | 190434000 | 43081000 |
| Wednesday, January 1, 2020 | 206506000 | 39330000 |
| Friday, January 1, 2021 | 238029000 | 43283000 |
| Saturday, January 1, 2022 | 250127000 | 48316000 |
| Sunday, January 1, 2023 | 293274000 | 54634000 |
Infusing magic into the data realm
In the ever-evolving pharmaceutical landscape, understanding cost structures is crucial. Amphastar Pharmaceuticals, Inc. and MiMedx Group, Inc. have shown distinct trajectories in their cost of revenue from 2014 to 2023. Amphastar's cost of revenue has surged by approximately 84%, reflecting its expanding operations and market reach. In contrast, MiMedx Group's cost of revenue increased by about 331%, indicating a significant scaling of its business activities.
These trends underscore the dynamic nature of the pharmaceutical industry, where strategic cost management is pivotal for sustained growth.
Cost Insights: Breaking Down Eli Lilly and Company and Amphastar Pharmaceuticals, Inc.'s Expenses
Cost Insights: Breaking Down Regeneron Pharmaceuticals, Inc. and Amphastar Pharmaceuticals, Inc.'s Expenses
Viatris Inc. vs MiMedx Group, Inc.: Efficiency in Cost of Revenue Explored
Comparing Cost of Revenue Efficiency: BioMarin Pharmaceutical Inc. vs MiMedx Group, Inc.
Comparing Cost of Revenue Efficiency: Halozyme Therapeutics, Inc. vs MiMedx Group, Inc.
Analyzing Cost of Revenue: Pharming Group N.V. and MiMedx Group, Inc.
Cost Insights: Breaking Down Grifols, S.A. and Amphastar Pharmaceuticals, Inc.'s Expenses
Cost of Revenue Comparison: Cytokinetics, Incorporated vs MiMedx Group, Inc.
Cost of Revenue Comparison: Ionis Pharmaceuticals, Inc. vs MiMedx Group, Inc.
Cost of Revenue Trends: Perrigo Company plc vs MiMedx Group, Inc.
Comparing Cost of Revenue Efficiency: Vericel Corporation vs Amphastar Pharmaceuticals, Inc.
Cost Insights: Breaking Down Supernus Pharmaceuticals, Inc. and Amphastar Pharmaceuticals, Inc.'s Expenses